J.P. Morgan has been appointed by Teva Pharmaceutical Industries as successor depositary bank for its American Depositary Receipt (ADR) program listed on the New York Stock Exchange (NYSE).
J.P. Morgan will manage the ADR program for Teva, a global pharmaceutical company based in Israel. The NYSE-listed ADRs trade under the symbol TEVA and the program ranks among the top three ADR programs in the EMEA region, by market value.
(JDC)